Page last updated: 2024-12-08

malabaricone a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

malabaricone A: from Myristica malabarica (rampatri), has antipromastigote activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Myristica malabaricaspecies[no description available]MyristicaceaeA family of flowering plants in the order Magnoliales. Many of the species are tropical and have fragrant wood and leaves.[MeSH]

Cross-References

ID SourceID
PubMed CID324062
CHEMBL ID1254269
SCHEMBL ID9117944
MeSH IDM0513353

Synonyms (20)

Synonym
63335-23-9
malabaricone a
nsc-287966
nsc287966
1-(2,6-dihydroxyphenyl)-9-phenyl-nonan-1-one
SCHEMBL9117944
bdbm50182487
1-(2,6-dihydroxyphenyl)-9-phenylnonan-1-one
CHEMBL1254269
malabaricon-a
phen-1,3-diol, 2-[9-phennonanoyl]-
IAXIHKJASWPASP-UHFFFAOYSA-N
1-(2,6-dihydroxyphenyl)-9-phenyl-1-nonanone #
DTXSID70314727
malabaricone-a
FS-8540
XM172958
1-(2,6-dihydroxyphenyl)-9-phenyl-1-nonanone
nsc 287966
AKOS040763673
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Pancreatic alpha-amylaseSus scrofa (pig)IC50 (µMol)19.07001.35304.31088.9300AID1497070
AlbuminBos taurus (cattle)IC50 (µMol)19.28003.00003.00003.0000AID1497073
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)1.31000.00000.933210.0000AID1308877
CholinesteraseEquus caballus (horse)IC50 (µMol)39.21000.00002.22149.4000AID1308869
Phosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)IC50 (µMol)3.00001.50002.57144.0000AID1600503; AID1600505
Phosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)IC50 (µMol)2.50001.00001.78574.0000AID1600504; AID1600506
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (24)

Processvia Protein(s)Taxonomy
cellular response to starvationAlbuminBos taurus (cattle)
negative regulation of mitochondrial depolarizationAlbuminBos taurus (cattle)
cellular response to calcium ion starvationAlbuminBos taurus (cattle)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
ceramide biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
sphingomyelin biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
apoptotic processPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
sphingolipid biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathwayPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
ceramide biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
sphingomyelin biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
sphingolipid biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
regulation of bone mineralizationPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
ceramide phosphoethanolamine biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
ceramide biosynthetic processPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
oxygen bindingAlbuminBos taurus (cattle)
DNA bindingAlbuminBos taurus (cattle)
fatty acid bindingAlbuminBos taurus (cattle)
protein bindingAlbuminBos taurus (cattle)
toxic substance bindingAlbuminBos taurus (cattle)
pyridoxal phosphate bindingAlbuminBos taurus (cattle)
metal ion bindingAlbuminBos taurus (cattle)
enterobactin bindingAlbuminBos taurus (cattle)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
ceramide phosphoethanolamine synthase activityPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
kinase activityPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
sphingomyelin synthase activityPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
ceramide cholinephosphotransferase activityPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
ceramide phosphoethanolamine synthase activityPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
protein bindingPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
kinase activityPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
sphingomyelin synthase activityPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
ceramide cholinephosphotransferase activityPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
extracellular regionAlbuminBos taurus (cattle)
extracellular spaceAlbuminBos taurus (cattle)
protein-containing complexAlbuminBos taurus (cattle)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
Golgi trans cisternaPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
Golgi membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
nucleusPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
endoplasmic reticulumPhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
plasma membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
plasma membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
endoplasmic reticulum membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
Golgi membranePhosphatidylcholine:ceramide cholinephosphotransferase 1 Homo sapiens (human)
Golgi membranePhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
nucleoplasmPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
Golgi apparatusPhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
plasma membranePhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
Golgi membranePhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
endoplasmic reticulum membranePhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
plasma membranePhosphatidylcholine:ceramide cholinephosphotransferase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID1600503Inhibition of SMS1 (unknown origin) stably expressed in mouse ZS cells using C6-NBD-ceramide as substrate preincubated for 30 mins followed by substrate addition and measured after 3 hrs by HPLC analysis2019ACS medicinal chemistry letters, Aug-08, Volume: 10, Issue:8
Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.
AID515751Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2010Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19
Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones.
AID1600505Noncompetitive inhibition of SMS1 (unknown origin) stably expressed in mouse ZS cells using 5 to 50 uM C6-NBD-ceramide as substrate preincubated for 30 mins followed by substrate addition and measured after 3 hrs by HPLC analysis2019ACS medicinal chemistry letters, Aug-08, Volume: 10, Issue:8
Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.
AID515726Induction of Escherichia coli pBR322 DNA cleavage assessed as linear form of DNA at 25 uM after 45 mins by agarose gel electrophoresis in presence of copper2010Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19
Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones.
AID1308871Selectivity index, ratio of IC50 for AChE (unknown origin) to IC50 for equine serum BChE2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID1600504Inhibition of SMS2 (unknown origin) stably expressed in mouse ZS cells using C6-NBD-ceramide as substrate preincubated for 30 mins followed by substrate addition and measured after 3 hrs by HPLC analysis2019ACS medicinal chemistry letters, Aug-08, Volume: 10, Issue:8
Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.
AID1497076Antidiabetic activity in rat L6 cells assessed as effect on 2-NBDG uptake at 25 uM pretreated for 24 hrs followed by 2-NBDG addition after 30 mins by FACS (Rvb = 20%)2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1308877Inhibition of AChE (unknown origin) using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID515725Induction of Escherichia coli pBR322 DNA cleavage at 25 uM after 45 mins under anoxic condition by agarose gel electrophoresis in presence of copper2010Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19
Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones.
AID1497078Antidiabetic activity in rat L6 cells assessed as increase in 2-NBDG uptake pretreated for 24 hrs followed by 2-NBDG addition after 30 mins by FACS2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1308870Selectivity index, ratio of IC50 for equine serum BChE to IC50 for AChE (unknown origin)2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID1497071Inhibition of rat intestinal alpha-glucosidase using p-nitrophenyl alpha-D-glucopyranoside as substrate pretreated for 10 mins followed by substrate addition measured after 5 mins2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1497075Antidiabetic activity in rat L6 cells assessed as effect on 2-NBDG uptake at 10 uM pretreated for 24 hrs followed by 2-NBDG addition after 30 mins by FACS (Rvb = 20%)2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1497070Inhibition of porcine pancreatic alpha-amylase using starch as substrate after 30 mins by iodine reagent based assay2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID515752Cytotoxicity against human MCF7 cells at 50 uM after 72 hrs by MTT assay relative to control2010Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19
Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones.
AID1497072Cytotoxicity against rat L6 cells up to 50 uM after 24 hrs by MTT assay2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1600506Noncompetitive inhibition of SMS2 (unknown origin) stably expressed in mouse ZS cells using 5 to 50 uM C6-NBD-ceramide as substrate preincubated for 30 mins followed by substrate addition and measured after 3 hrs by HPLC analysis2019ACS medicinal chemistry letters, Aug-08, Volume: 10, Issue:8
Malabaricone C as Natural Sphingomyelin Synthase Inhibitor against Diet-Induced Obesity and Its Lipid Metabolism in Mice.
AID1308869Inhibition of equine serum BChE using S-butyrylthiocholine chloride as substrate incubated for 30 mins by Ellman's microplate assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID1497077Antidiabetic activity in rat L6 cells assessed as effect on 2-NBDG uptake at 50 uM pretreated for 24 hrs followed by 2-NBDG addition after 30 mins by FACS (Rvb = 20%)2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1497073Antiglycation activity in bovine serum albumin assessed as inhibition of advanced glycated end product formation after 24 hrs in presence of alpha-D-glucose by fluorescence assay2018Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12
Antidiabetic potential of phytochemicals isolated from the stem bark of Myristica fatua Houtt. var. magnifica (Bedd.) Sinclair.
AID1308874Inhibition of AChE (unknown origin) at 100 ug/ml using acetylthiocholine iodide as substrate incubated for 30 mins by Ellman's microplate assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID515724Induction of Escherichia coli pBR322 DNA cleavage assessed as open circular form of DNA at 25 uM after 45 mins by agarose gel electrophoresis in presence of copper2010Bioorganic & medicinal chemistry, Oct-01, Volume: 18, Issue:19
Comparative nuclease and anti-cancer properties of the naturally occurring malabaricones.
AID1308875Inhibition of equine serum BChE at 100 ug/ml using S-butyrylthiocholine chloride as substrate incubated for 30 mins by Ellman's microplate assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Natural cholinesterase inhibitors from Myristica cinnamomea King.
AID713894Antimycobacterial activity against Mycobacterium tuberculosis H37Ra2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's11 (91.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.64 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]